ACS Cancer Conference: Improving Cancer Care for All 2024 - Non CME

On behalf of the American College of Surgeons (ACS), it is our pleasure to share with you the 2024 ACS Cancer Conference content from our event in Austin, Texas!  We were happy to have you join us for this year’s program focused on our theme of Improving Cancer Care for All, and hope this conference will leave you with new knowledge, resources, and ideas to take back to your home institutions.  Whether it’s learning about the updated National Accreditation Program for Breast Centers (NAPBC) standards, hearing the latest on quality improvement efforts, finding out how recent health equity and advocacy efforts impact our work and patients, or learning about how to best prepare for a site visit, this year’s conference has something to offer for anybody participating in ACS Cancer Programs.

Target Audience

  • Chief Executive Officers
  • Cancer Program Administrators
  • Breast Program Directors
  • Breast Program Leadership Committee Members
  • Rectal Cancer Program Directors
  • Rectal Cancer Program Coordinators
  • Rectal Cancer Multidisciplinary Team Members
  • Cancer Committee Chairs
  • Cancer Committee Members
  • Physicians (Cancer Liaison Physicians, diagnostic radiologists, pathologists, surgeons, medical oncologists, radiation oncologists)
  • State Chairs
  • Quality Improvement Professionals
  • Physician Assistants
  • Advanced Practice Providers
  • Occupational Therapists
  • Physical Therapists
  • Genetic Counselors
  • Navigators
  • Nurses
  • Cancer Registrars

Learning Objectives

  • Describe changes to accreditation standards, services and resources available to cancer programs, and important future developments available to accredited cancer programs.
  • Illustrate how the quality improvement process, quality measures, National Cancer Database (NCDB) real-time reports, American Joint Committee on Cancer (AJCC) staging protocols, operative standards and synoptic operative reports, and other tools can be applied in local programs to improve performance and care for patients with cancer.
  • Develop and implement efficient and effective program structures and processes to ensure a successful accreditation site visit.

Contact

  • For questions about the course, please contact cancerprogramevents@facs.org.
  • If you have any technical questions, contact elearning@facs.org. 
Course summary
Available credit: 
  • 15.25 CE Contact hours
  • 15.25 Certificate of Completion
Course opens: 
05/28/2024
Course expires: 
01/31/2025
Rating: 
0

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speakers / Moderators / Discussants / Authors

Oluwamuyiwa Adebayo - (Nothing to Disclose)               
Erika Akers - (Nothing to Disclose)              
Arslan Amir - (Nothing to Disclose)              
Carrie Antonelli - (Nothing to Disclose)               
Elliot Asare - (Nothing to Disclose)           
Maria Louise Avenido - (Nothing to Disclose)               
Carol-Ann Benn    - (Nothing to Disclose)               
Aaron Bleznak- (Nothing to Disclose)               
Daniel Boffa - Iovance , Epic Sciences, to attend and advisory panel  meeting collaboration, stipend, they ran experiments for free
Jessica Brandt - (Nothing to Disclose)               
Vicki Chiappetta - (Nothing to Disclose)          
Erin Collins-Buchanan- (Nothing to Disclose)               
Carolyn Compton - (Nothing to Disclose)          
Celeste Cruz- (Nothing to Disclose)               
Ian Csencsits - (Nothing to Disclose)          
Viktoriia Dailey    - (Nothing to Disclose)               
Edward Diaz - (Nothing to Disclose)               
Lauren Dori - (Nothing to Disclose)               
Lesly Dossett - (Nothing to Disclose)               
Brian Edwards - (Nothing to Disclose)               
Linda Farkas- (Nothing to Disclose)               
Marie Fefferman - (Nothing to Disclose)          
Emmanuel Gabriel - (Nothing to Disclose)               
Christine Garcia     Pfizer, honorarium, speaker
Sharon Gentry - (Nothing to Disclose)               
Richard Glick - (Nothing to Disclose)               
Brianna Graham - (Nothing to Disclose)               
James Gulley - (Nothing to Disclose)               
Emmy Hammons - (Nothing to Disclose)               
Victoria Haney - (Nothing to Disclose)               
Dawn Hayes - (Nothing to Disclose)               
Susan Hedlund - (Nothing to Disclose)               
Tina Hieken - (Nothing to Disclose)               
Suzanne Hoekstra - (Nothing to Disclose)               
Vanessa Hoffmann - (Nothing to Disclose)               
Mallori Hooker    - (Nothing to Disclose)               
Kyuseok Im - (Nothing to Disclose)               
Lauren Janczewski - (Nothing to Disclose)               
Paul Jeffers - (Nothing to Disclose)               
Kendra Johnson     - (Nothing to Disclose)               
Edward Joseph - (Nothing to Disclose)               
Rachel Joung - (Nothing to Disclose)               
Lyndsey Kilgore    - (Nothing to Disclose)               
Laurie Kirstein - (Nothing to Disclose)               
Michelle Kondracki - (Nothing to Disclose)               
Abha Kulkarni - (Nothing to Disclose)               
Ron Landmann- Ethicon, Natera    Consulting fees, consulting fees    consultant, consultant
Meeghan Lautner- (Nothing to Disclose)               
Raymond Liu Genentech, AstraZeneca, Exact Sciences, Biotheranostics, Beigene, Pfizer.research grant, research grant, research grant, research grant, research grant, think tank committee member    research grant, research grant, research grant, research grant, research grant, no honorarium, Sponsor provided travel lodging expenses for think tank
Denise Lutkemeier - (Nothing to Disclose)               
Heather Lyu - (Nothing to Disclose)               
Jenna Mancinelli - (Nothing to Disclose)           
Linda Martin Astrazeneca, Genentech, Ethicon, Ontarget laboratories honraria; investigator support, honoraria, honoraria, honoraria    Advisory board; principle investigator, advisory board; speaker’s bureau, speakers bureau, consulting; investigator for clinical trial
Hassan Masoudpoor - (Nothing to Disclose)               
Ryan McCabe - (Nothing to Disclose)               
James McLoughlin - (Nothing to Disclose)               
Stacey Milan - (Nothing to Disclose)               
Kimberly Miller    - (Nothing to Disclose)               
Kelsey Montgomery - (Nothing to Disclose)          
Gloria Morris - (Nothing to Disclose)               
Timothy  Mullett – oncolens, ownership, interest advisor
David Mullins - (Nothing to Disclose)               
Shelby Murphy    - (Nothing to Disclose)               
Daniella Natanov - (Nothing to Disclose)               
Toan Thien (Tony) Nguyen -aptitude health, consultant fee, consultant   
Jamie Partlow - (Nothing to Disclose)               
LeAnn Perkins - (Nothing to Disclose)               
Garrett Peters - (Nothing to Disclose)               
Lindsey Pimentel - (Nothing to Disclose)               
Broc Pollinger - (Nothing to Disclose)               
Marcella Ramahi - (Nothing to Disclose)               
ERIN REUTER- (Nothing to Disclose)               
Jonathan Rubin    - (Nothing to Disclose)               
Shayla Scarlett - 3M, individual stock owner of 10 shares in retirement account    N/A
Camille Servodidio -- (Nothing to Disclose)               
Charles Shelton    - (Nothing to Disclose)               
MOHUMMAD SIDDIQUI    - (Nothing to Disclose)           
Nicole Sinclair - (Nothing to Disclose)               
Rebecca A.  Snyder- (Nothing to Disclose)               
Jessica Steadman - (Nothing to Disclose)               
Amalia Stefanou - (Nothing to Disclose)               
James Sun - (Nothing to Disclose)               
Magesh Sundaram - (Nothing to Disclose)               
Chad Teven - (Nothing to Disclose)               
Whittney Thoman - (Nothing to Disclose)               
Stephanie Thomas - (Nothing to Disclose)               
Danielle Thompson - (Nothing to Disclose)               
Theodoros Voloyiannis    - (Nothing to Disclose)               
Mark Whiteford - (Nothing to Disclose)    
Lee Wilke -Elucent medical, perimeter medical, Stock options (less than 5%), Institutional support for clinical trial, Founder, instutional PI of clinical trial- no salary support
Chris Wilson- (Nothing to Disclose)               
Emma Zimmerman- (Nothing to Disclose)
Judy Boughey, MBBChir, FACS - Cairns Surgical, SymBioSys, Physicians Education Resource (PER)
PeerView, EndoMag, research support to my institution for clinical trial, financial support for time spent on data safety monitoring committee, royalty share for co-developed IP, honorarium, honorarium, honorarium, Co-PI, member of DSMC, collaboration speaker at educational conference, speaker at educational conference, speaker at educational conference
Katherine Yao, MD, FACS - (Nothing to Disclose)    
Kinberly Yee, MD, FACS    - (Nothing to Disclose)
Mediget Teshome, MD, FACS – Endomagnetics travel/accommodations for TBCC22 conference    speaker
Elizabeth Wick, MD, FACS - (Nothing to Disclose)        
Ronald Weigel, MD, FACS - (Nothing to Disclose)    
Anthony Yang, MD, FACS - (Nothing to Disclose)    

Planning Committee/ Editorial Committee

Thomas Baker, MD, FCAP - (Nothing to Disclose)            
Jill Dietz, MD, MHCM, FACS- Cyduct Diagnostics, Peace Medical LLC, Options (currently no value), N/A
Laurie Kirstein, MD, FACS - (Nothing to Disclose)            
Denise Mammolito, MD, FACS - (Nothing to Disclose)            
Alexander Olawaiye, MD, FACS, MRCOG, FACOG     -AstraZeneca, Corcept, Therapeutics ,GSK, Merck, Elsai
,Dalichi Sankyo, Honorarium for advisory board meetings , Research grant, Honorarium for advisory board meetings, Honorarium for advisory board meetings, Honorarium for advisory board meetings 
,Honorarium for advisory board meetings , Advisory board meetings, Research, Advisory board meetings
,Advisory board meetings, Advisory board meetings, Advisory board meetings
Rebecca Snyder, MD, FACS - (Nothing to Disclose)            
Kimberly Yee, MD, FACS    - (Nothing to Disclose)            
Ronald Weigel, MD, FACS - (Nothing to Disclose)            
Mehra Golshan, MD, MBA, FACS - (Nothing to Disclose)        
Jane Meisel, MD - Pfizer, Olema, Sermonix, Astrazeneca, Novartis, Puma, Seagen, Genentech, consulting GSK, institutional research funding and consulting honoraria, consulting honoraria, consultant and servicing as institutional PI of trials
Mediget Teshome, MD, FACS - endomagnetics    travel/accommodations for TBCC22 conference    speaker
Elizabeth Wick, MD, FACS - (Nothing to Disclose)        
Anthony Yang, MD, FACS - (Nothing to Disclose)            
Katherine Yao, MD, FACS - (Nothing to Disclose)            
Judy Boughey, MBBChir, FACS - Cairns Surgical, SymBioSys, Physicians Education Resource (PER)
PeerView, EndoMag, research support to my institution for clinical trial, financial support for time spent on data safety monitoring committee, royalty share for co-developed IP, honorarium, honorarium
Honorarium, Co-PI, member of DSMC, collaboration speaker at educational conference, speaker at educational conference, speaker at educational conference

Available Credit

  • 15.25 CE Contact hours
  • 15.25 Certificate of Completion
Please login or register to take this course.